The impact of Mundipharma's reduction of narcotic analgesics business is also affecting Korean corporations. A major reorganization is taking place, cutting two-thirds of the department's workforce. According to the pharmaceutical industry on the 3rd, Mundipharma is conducting ERP with the aim of finishing at the end of August. The target is the department in charge of narcotic painkillers among the two Rx departments. This is the first time Mundipharma has conducted an ERP. The voluntary retirement is attributed to global Mundipharma's massive reduction of its narcotic painkillers business. This is because opioid-based narcotic painkillers have emerged as a social problem in the U.S. due to death and addiction caused